Literature DB >> 14169591

[REGIONAL CHEMOTHERAPY OF MALIGNANT TUMORS. II. TREATMENT WITH MASSIVE DOSES OF NITROGEN MUSTARD WITH TEMPORARY COMPRESSION OF THE ABDOMINAL AORTA AND ITS COLLATERAL ARTERIES].

H F OETTGEN, P CLIFFORD, J L BEECHER, J H GILLMORE.   

Abstract

Entities:  

Keywords:  BONE MARROW; CARCINOMA; INJECTIONS, INTRAVENOUS; MECHLORETHAMINE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM THERAPY; PATHOLOGY; PELVIC BONES; TOURNIQUETS

Mesh：

Substances：

Year:  1964        PMID： 14169591     DOI： 10.1007/BF01487946

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  10 in total

1.  HAEMODYNAMIC EFFECTS OF OCCLUSION OF ABDOMINAL AORTA DURING NITROGEN MUSTARD THERAPY.

Authors:  J R HARRIES; F BROWN; J L BEECHER; H F OETTGEN
Journal:  Br Med J       Date:  1963-09-28

2.  Nitrogen mustard therapy with aortic occlusion in nasopharyngeal carcinoma.

Authors:  P CLIFFORD; H G OETTGEN; J L BEECHER; F P BROWN; J R HARRIES; W E LAWES
Journal:  Br Med J       Date:  1963-05-11

3.  High-dose nitrogen mustard therapy with intermittent aortic occlusion.

Authors:  J K DUFF; J DENNIS; R A CLIFT; P CLIFFORD; H F OETTGEN
Journal:  Br Med J       Date:  1961-12-09

4.  Nitrogen-mustard therapy combined with autologous marrow infusion.

Authors:  P CLIFFORD; R A CLIFT; J K DUFF
Journal:  Lancet       Date:  1961-04-01       Impact factor: 79.321

5.  Malignant disease of the nose, paranasal sinuses and post-nasal space in East Africa.

Authors:  P CLIFFORD
Journal:  J Laryngol Otol       Date:  1961-08       Impact factor: 1.469

6.  Autologous bone marrow infusion as an adjunct in therapy of malignant disease.

Authors:  W McFARLAND; N B GRANVILLE; W DAMESHEK
Journal:  Blood       Date:  1959-05       Impact factor: 22.113

7.  Massive nitrogen mustard therapy in Hodgkin's disease with protection of bone marrow by tourniquets.

Authors:  M E CONRAD; W H CROSBY
Journal:  Blood       Date:  1960-08       Impact factor: 22.113

8.  Meaningful clinical classification of therapeutic responses to anticancer drugs.

Authors:  D A KARNOFSKY
Journal:  Clin Pharmacol Ther       Date:  1961 Nov-Dec       Impact factor: 6.875

9.  Histopathologic effects of nitrogen mustard therapy upon normal and neoplastic hematopoietic tissues.

Authors:  M BLOCK; C L SPURR
Journal:  Am J Clin Pathol       Date:  1948-09       Impact factor: 2.493

10.  Midtorso occlusion for regional cancer chemotherapy.

Authors:  D G MILLER; W LAWRENCE; M KIM; D DORENCAMP; H T RANDALL
Journal:  Cancer Chemother Rep       Date:  1962-05
  10 in total
  3 in total

1.  [Effect of radiomimetics and roentgen rays on the permeability of the blood-brain barrier].

Authors:  K Zipf; W Rössner; K Tempel
Journal:  Naunyn Schmiedebergs Arch Pharmakol Exp Pathol       Date:  1966

2.  INTENSIVE NITROGEN MUSTARD THERAPY WITH ABDOMINAL AORTIC OCCLUSION IN NASOPHARYNGEAL CARCINOMA.

Authors:  P CLIFFORD; B V BHARDWAJ; L R WHITTAKER
Journal:  Br J Cancer       Date:  1965-03       Impact factor: 7.640

3.  DIMETHYL MYLERAN THERAPY COMBINED WITH ABDOMINAL AORTIC OCCLUSION.

Authors:  P CLIFFORD; R A CLIFT; A G KHAN; G M TIMMIS
Journal:  Br J Cancer       Date:  1964-09       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.